CEO Arun Menawat highlighted the CAPTAIN trial results presented at the American Urological Association Meeting, describing them as establishing TULSA's statistical superiority over robotic radical ...
Components of the Long March 5B (Y2) to launch the Chinese space station core module at a facility in Tianjin. Credit: CMSA HELSINKI — The Long March 5B heavy-lift rocket to launch China’s first space ...
Hosted on MSN
Profound Medical to launch AI-powered BPH module
Profound Medical (PROF) announced the upcoming launch of its TULSA-AI Volume Reduction module for optimizing the treatment of patients with benign prostatic hyperplasia, or enlarged prostate, at the ...
TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
New BPH module and clinical data reinforce the TULSA Procedure™’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption BPH is a non-cancerous enlargement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback